DMS Imaging (XBRU:ALIMG) EV-to-Revenue : 1.20 (As of May. 04, 2024)

View and export this data going back to 2016. Start your Free Trial

What is DMS Imaging EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, DMS Imaging's enterprise value is €48.51 Mil. DMS Imaging's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €40.56 Mil. Therefore, DMS Imaging's EV-to-Revenue for today is 1.20.

The historical rank and industry rank for DMS Imaging's EV-to-Revenue or its related term are showing as below:

XBRU:ALIMG' s EV-to-Revenue Range Over the Past 10 Years
Min: -1416.07 Med: 1.19 Max: 11578.04
Current: 1.2

During the past 12 years, the highest EV-to-Revenue of DMS Imaging was 11578.04. The lowest was -1416.07. And the median was 1.19.

XBRU:ALIMG's EV-to-Revenue is ranked better than
85.41% of 1035 companies
in the Biotechnology industry
Industry Median: 8.07 vs XBRU:ALIMG: 1.20

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-04), DMS Imaging's stock price is €0.024. DMS Imaging's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.03. Therefore, DMS Imaging's PS Ratio for today is 0.89.

DMS Imaging EV-to-Revenue Historical Data

The historical data trend for DMS Imaging's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DMS Imaging EV-to-Revenue Chart

DMS Imaging Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

0.42

2.63

1.18

DMS Imaging Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.42	-	2.63	-	1.18

Competitive Comparison of DMS Imaging's EV-to-Revenue

For the Biotechnology subindustry, DMS Imaging's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DMS Imaging's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DMS Imaging's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where DMS Imaging's EV-to-Revenue falls into.

DMS Imaging EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

DMS Imaging's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	48.513	/	40.564
	=	1.20

DMS Imaging's current Enterprise Value is €48.51 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DMS Imaging's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €40.56 Mil.

DMS Imaging (XBRU:ALIMG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

DMS Imaging's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.024	/	0.027
	=	0.89

DMS Imaging's share price for today is €0.024.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.03.

DMS Imaging EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of DMS Imaging's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

DMS Imaging (XBRU:ALIMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (XBRU:ALIMG) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

AS0:Germany

Address

7 Rue des Chasseurs Ardennais, Liege, BEL, 4031

Website

https://www.dms-imaging.com

DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (XBRU:ALIMG) Headlines

No Headlines